Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Competitive assay formats for high-throughput affinity arrays.

Richard Barry1, Tricia Diggle, Jonathan Terrett

  • 1Oxford GlycoSciences (UK) Ltd., Abingdon, United Kingdom.

Journal of Biomolecular Screening
|July 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project.

The British journal of ophthalmology·2026
Same author

Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

Blood advances·2026
Same author

Outcomes in Neovascular Age-Related Macular Degeneration with Visit Gaps under Anti-VEGF Therapy in Daily Practice: Data from the Fight Retinal Blindness! Registry.

Ophthalmology. Retina·2026
Same author

Visual noise in augmented reality improves vision in age-related macular degeneration.

npj aging·2026
Same author

Twelve-Month Real-World Outcomes of Faricimab for Treatment-Naive Neovascular AMD in Australia.

Clinical & experimental ophthalmology·2026
Same author

Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry.

Clinical & experimental ophthalmology·2025

This study introduces a new method for quantifying biomolecule levels in unlabeled samples using protein-binding arrays. The novel displacement strategy overcomes limitations of traditional arrays, enabling more accurate differential expression analysis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Assay Development

Background:

  • Traditional affinity arrays face challenges with limited characterized antibodies and variable affinities.
  • Optimizing assay conditions for diverse protein concentrations and properties is difficult.
  • These limitations restrict the multiplexing capabilities of parallel affinity assays.

Purpose of the Study:

  • To develop a novel method for quantifying differential biomolecule levels using unlabeled samples.
  • To overcome the limitations of traditional protein-binding arrays for differential expression analysis.
  • To enable highly multiplexed parallel affinity assays with reduced antibody affinity requirements.

Main Methods:

  • Utilized a novel displacement strategy for competitive assays on protein-binding arrays.

Related Experiment Videos

  • Employed unlabeled samples for biomolecule quantitation.
  • Assessed differential expression of biomolecules.

    • Main Results:

    • The displacement strategy accommodates a wider range of antibodies, reducing the need for matched affinities.
    • Competitive assays demonstrated significantly higher tolerance for nonspecific background noise.
    • The dynamic range of protein concentration quantitation is limited only by detection system sensitivity.

    Conclusions:

    • The developed method offers a robust approach for differential biomolecule quantitation.
    • This technique enhances the feasibility of highly multiplexed parallel affinity assays.
    • It addresses key limitations in current protein-binding array technologies for expression analysis.